|

gallium (68Ga) gozetotide (25μg) Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 3: 1

Top Sponsors

  • Novartis Pharmaceuticals1

Indications

  • Oligometastatic Prostate Cancer (OMPC)1
  • Cancer1

Fayetteville, Arkansas1 trial

An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.

Highlands Oncology Group

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.